On top of that, we could save the anxiety and cost of unnecessary biopsies for false positives.
Women are required or recommended to take this test every few years, so imagine the multiplicative effect of that.
Note that this test is useful for ovarian cancer recurrence test too.
- Forums
- ASX - By Stock
- Ann: Cleo Commences US Regulatory Process with FDA
On top of that, we could save the anxiety and cost of...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add COV (ASX) to my watchlist
|
|||||
Last
35.0¢ |
Change
-0.055(13.6%) |
Mkt cap ! $28.56M |
Open | High | Low | Value | Volume |
40.0¢ | 40.0¢ | 34.5¢ | $254.0K | 701.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 124925 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 1422 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 124925 | 0.350 |
2 | 58826 | 0.340 |
1 | 100000 | 0.335 |
2 | 53030 | 0.330 |
2 | 30000 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 1422 | 1 |
0.390 | 10000 | 1 |
0.395 | 20207 | 1 |
0.405 | 7020 | 1 |
0.440 | 72010 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
COV (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online